Skip to content
Screener

Haemonetics HAE MedSurg — Restructuring related costs

Other segment segments

Corporate
-$40K—
Apheresis
$0—

Similar metrics at other companies

Novanta logo
NOVTUnallocated Costs — Restructuring And Related Cost Incurred Cost
$856.75K+312%
Regal Rexnord logo
RRXRestructuring And Related Cost Expected Cost1
$13.6M+5.4%
MBC
MBCRestructuring And Related Cost Expected Cost1
$8.1M—
Xerox Holdings Corporation logo
XRXRestructuring And Related Cost Expected Cost1
$78M+21.9%
Bumble, Inc. logo
BMBLRestructuring And Related Cost Expected Cost1
$16M—
Matthews International logo
MATWRestructuring And Related Cost Expected Cost1
$42M—

Other financials

Income statement

See full
Revenue$339.4M+5.6%
Gross profit$202.8M+5.5%
Operating income$57.5M+6.7%
Net income$33.0M-3.0%
EPS (diluted)$0.72+2.9%

Balance sheet

See full
Cash & equivalents$223.4M-23.7%
Total debt$1.2B-4.1%
Total equity$837.1M-5.1%
Total assets$2.4B-3.9%

Cash flow

See full
Operating cash flow$52.3M+201%
CapEx$7.9M+111%
Free cash flow$44.4M+226%

Valuation

See full
Market cap$3.87B+6.3%
Enterprise value$4.82B+5.4%
P/E25.7×-10.5×
P/S2.9×+0.2×

Profitability

See full
Gross margin59%+2.1pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin21.5%+7.5pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.4×0.0×
Current ratio3.1×+1.4×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept hae:RestructuringRelatedCosts.

The source filing: Haemonetics’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:09 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000313143-26-000120
Line itemThree Months Ended / June 27, 2026Three Months Ended / June 28, 2025
Corporate(24)1,142
Total$2,298$1,266
Restructuring related costs
Apheresis—$9
MedSurg——
Corporate(40)49
Total$(40)$58
Total restructuring and restructuring related costs$2,258$1,324

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Haemonetics's medsurg — restructuring related costs?
Haemonetics (HAE) reported medsurg — restructuring related costs of $0 in Q2 2026.
What does medsurg — restructuring related costs mean?
Captures expenses directly associated with organizational restructuring, facility consolidations, or workforce reductions within the MedSurg segment. Monitoring these costs helps investors assess the impact of strategic realignments on the segment's short-term profitability.

Ask your AI about Haemonetics's medsurg — restructuring related costs.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude